Aurobindo Pharma Limited (NSE:AUROPHARMA)

Aurobindo Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	710,785	637,941	303,575	391,729	516,388	242,081
Market Cap Growth	22.03%	110.14%	-22.50%	-24.14%	113.31%	-47.32%
Enterprise Value	726,441	632,994	283,996	394,408	532,915	281,518
Last Close Price	1223.80	1088.75	515.81	655.80	858.85	400.76
PE Ratio	20.46	20.11	15.75	14.79	9.68	8.51
Forward PE	16.85	17.77	12.19	12.83	14.88	7.98
PS Ratio	2.30	2.20	1.22	1.67	2.08	1.05
PB Ratio	2.30	2.14	1.13	1.59	2.36	1.44
P/TBV Ratio	2.65	2.46	1.31	1.85	2.73	1.78
P/FCF Ratio	-	-	-	13.22	27.31	8.07
P/OCF Ratio	-	26.20	12.72	7.81	15.51	5.53
PEG Ratio	1.48	0.78	1.63	2.09	1.35	0.60
EV/Sales Ratio	2.35	2.18	1.14	1.68	2.15	1.22
EV/EBITDA Ratio	10.96	10.98	7.81	9.15	9.88	5.86
EV/EBIT Ratio	14.53	14.41	11.31	11.93	11.97	7.15
EV/FCF Ratio	-	-	-	13.31	28.18	9.39
Debt / Equity Ratio	0.27	0.22	0.20	0.12	0.24	0.35
Debt / EBITDA Ratio	1.27	1.14	1.43	0.65	0.97	1.21
Debt / FCF Ratio	-	-	-	0.96	2.82	1.98
Asset Turnover	-	0.68	0.67	0.69	0.79	0.83
Inventory Turnover	-	1.42	1.45	1.26	1.22	1.34
Quick Ratio	-	0.96	0.98	1.10	0.90	0.67
Current Ratio	-	1.98	1.88	2.22	1.86	1.44
Return on Equity (ROE)	-	11.18%	7.50%	11.39%	27.53%	18.52%
Return on Assets (ROA)	-	6.46%	4.25%	6.10%	8.87%	8.89%
Return on Capital (ROIC)	8.45%	8.00%	5.27%	7.56%	11.13%	11.29%
Return on Capital Employed (ROCE)	-	13.40%	8.80%	12.80%	19.20%	22.50%
Earnings Yield	4.91%	4.97%	6.35%	6.76%	10.33%	11.75%
FCF Yield	-	-0.54%	-0.06%	7.56%	3.66%	12.39%
Dividend Yield	0.25%	0.41%	0.58%	1.37%	0.47%	0.75%
Payout Ratio	-	8.31%	22.80%	9.96%	4.39%	6.17%
Buyback Yield / Dilution	0.48%	-	-	-	-	0.00%
Total Shareholder Return	0.73%	0.41%	0.58%	1.37%	0.47%	0.75%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.